Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
TSE:4536
Price:
1 598 JPY
-0.34%
Market Closed
Updated:
May 17, 2024
Santen Pharmaceutical Co Ltd
Interest Income Expense
|
Santen Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Interest Income Expense
-¥8.7B
|
CAGR 3-Years
-159%
|
CAGR 5-Years
-76%
|
CAGR 10-Years
N/A
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Interest Income Expense
-¥161.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Interest Income Expense
¥25.6B
|
CAGR 3-Years
136%
|
CAGR 5-Years
47%
|
CAGR 10-Years
96%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Interest Income Expense
¥30.7B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Interest Income Expense
¥3.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Astellas Pharma Inc
TSE:4503
|
Interest Income Expense
-¥3.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
See Also
What is Santen Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
-8.7B
JPY
-8.7B
JPY
Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's Interest Income Expense amounts to -8.7B JPY.
What is Santen Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-76%
-76%
Over the last year, the Interest Income Expense growth was -259%. The average annual Interest Income Expense growth rates for Santen Pharmaceutical Co Ltd have been -159% over the past three years , -76% over the past five years .
You don't have any saved screeners yet
